Your browser doesn't support javascript.
Prevalence and risk factors of psychiatric symptoms and diagnoses before and during the COVID-19 pandemic: findings from the ELSA-Brasil COVID-19 mental health cohort.
Brunoni, André Russowsky; Suen, Paulo Jeng Chian; Bacchi, Pedro Starzynski; Razza, Lais Boralli; Klein, Izio; Dos Santos, Leonardo Afonso; de Souza Santos, Itamar; da Costa Lane Valiengo, Leandro; Gallucci-Neto, José; Moreno, Marina Lopes; Pinto, Bianca Silva; de Cássia Silva Félix, Larissa; de Sousa, Juliana Pereira; Viana, Maria Carmen; Forte, Pamela Marques; de Altisent Oliveira Cardoso, Marcia Cristina; Bittencourt, Marcio Sommer; Pelosof, Rebeca; de Siqueira, Luciana Lima; Fatori, Daniel; Bellini, Helena; Bueno, Priscila Vilela Silveira; Passos, Ives Cavalcante; Nunes, Maria Angelica; Salum, Giovanni Abrahão; Bauermeister, Sarah; Smoller, Jordan W; Lotufo, Paulo Andrade; Benseñor, Isabela Martins.
  • Brunoni AR; Centro de Pesquisas Clínicas e Epidemiológicas, Hospital Universitário, Universidade de São Paulo, São Paulo, Brazil.
  • Suen PJC; Departamento de Clínica Médica, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
  • Bacchi PS; Departamento e Instituto de Psiquiatria & Laboratory of Neurosciences (LIM-27), Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
  • Razza LB; Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
  • Klein I; Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
  • Dos Santos LA; Departamento e Instituto de Psiquiatria & Laboratory of Neurosciences (LIM-27), Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
  • de Souza Santos I; Departamento de Clínica Médica, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
  • da Costa Lane Valiengo L; Departamento e Instituto de Psiquiatria & Laboratory of Neurosciences (LIM-27), Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
  • Gallucci-Neto J; Departamento e Instituto de Psiquiatria & Laboratory of Neurosciences (LIM-27), Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
  • Moreno ML; Departamento e Instituto de Psiquiatria & Laboratory of Neurosciences (LIM-27), Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
  • Pinto BS; Centro de Pesquisas Clínicas e Epidemiológicas, Hospital Universitário, Universidade de São Paulo, São Paulo, Brazil.
  • de Cássia Silva Félix L; Departamento de Clínica Médica, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
  • de Sousa JP; Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
  • Viana MC; Departamento e Instituto de Psiquiatria & Laboratory of Neurosciences (LIM-27), Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
  • Forte PM; Departamento e Instituto de Psiquiatria & Laboratory of Neurosciences (LIM-27), Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
  • de Altisent Oliveira Cardoso MC; Centro de Pesquisas Clínicas e Epidemiológicas, Hospital Universitário, Universidade de São Paulo, São Paulo, Brazil.
  • Bittencourt MS; Departamento de Clínica Médica, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
  • Pelosof R; Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
  • de Siqueira LL; Departamento e Instituto de Psiquiatria & Laboratory of Neurosciences (LIM-27), Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
  • Fatori D; Departamento e Instituto de Psiquiatria & Laboratory of Neurosciences (LIM-27), Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
  • Bellini H; Departamento e Instituto de Psiquiatria & Laboratory of Neurosciences (LIM-27), Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
  • Bueno PVS; Department of Social Medicine, Postgraduate Program in Public Health, Center of Psychiatric Epidemiology (CEPEP), Federal University of Espírito Santo, Vitória, Brazil.
  • Passos IC; Departamento e Instituto de Psiquiatria & Laboratory of Neurosciences (LIM-27), Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
  • Nunes MA; Departamento e Instituto de Psiquiatria & Laboratory of Neurosciences (LIM-27), Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
  • Salum GA; Centro de Pesquisas Clínicas e Epidemiológicas, Hospital Universitário, Universidade de São Paulo, São Paulo, Brazil.
  • Bauermeister S; Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
  • Smoller JW; Departamento e Instituto de Psiquiatria & Laboratory of Neurosciences (LIM-27), Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
  • Lotufo PA; Departamento e Instituto de Psiquiatria & Laboratory of Neurosciences (LIM-27), Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
  • Benseñor IM; Departamento e Instituto de Psiquiatria & Laboratory of Neurosciences (LIM-27), Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Psychol Med ; : 1-12, 2021 Apr 21.
Article in English | MEDLINE | ID: covidwho-2253162
ABSTRACT

BACKGROUND:

There is mixed evidence on increasing rates of psychiatric disorders and symptoms during the coronavirus disease 2019 (COVID-19) pandemic in 2020. We evaluated pandemic-related psychopathology and psychiatry diagnoses and their determinants in the Brazilian Longitudinal Study of Health (ELSA-Brasil) São Paulo Research Center.

METHODS:

Between pre-pandemic ELSA-Brasil assessments in 2008-2010 (wave-1), 2012-2014 (wave-2), 2016-2018 (wave-3) and three pandemic assessments in 2020 (COVID-19 waves in May-July, July-September, and October-December), rates of common psychiatric symptoms, and depressive, anxiety, and common mental disorders (CMDs) were compared using the Clinical Interview Scheduled-Revised (CIS-R) and the Depression Anxiety Stress Scale-21 (DASS-21). Multivariable generalized linear models, adjusted by age, gender, educational level, and ethnicity identified variables associated with an elevated risk for mental disorders.

RESULTS:

In 2117 participants (mean age 62.3 years, 58.2% females), rates of CMDs and depressive disorders did not significantly change over time, oscillating from 23.5% to 21.1%, and 3.3% to 2.8%, respectively; whereas rate of anxiety disorders significantly decreased (2008-2010 13.8%; 2016-2018 9.8%; 2020 8%). There was a decrease along three wave-COVID assessments for depression [ß = -0.37, 99.5% confidence interval (CI) -0.50 to -0.23], anxiety (ß = -0.37, 99.5% CI -0.48 to -0.26), and stress (ß = -0.48, 99.5% CI -0.64 to -0.33) symptoms (all ps < 0.001). Younger age, female sex, lower educational level, non-white ethnicity, and previous psychiatric disorders were associated with increased odds for psychiatric disorders, whereas self-evaluated good health and good quality of relationships with decreased risk.

CONCLUSION:

No consistent evidence of pandemic-related worsening psychopathology in our cohort was found. Indeed, psychiatric symptoms slightly decreased along 2020. Risk factors representing socioeconomic disadvantages were associated with increased odds of psychiatric disorders.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Country/Region as subject: South America / Brazil Language: English Journal: Psychol Med Year: 2021 Document Type: Article Affiliation country: S0033291721001719

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Country/Region as subject: South America / Brazil Language: English Journal: Psychol Med Year: 2021 Document Type: Article Affiliation country: S0033291721001719